Skip to content

Madrigal Pharmaceuticals, Inc. MDGL Common Stock Shares Issued

Common Stock Shares Issued at other companies

Our Bond, Inc.
 logo
Our Bond, Inc. OBAI
21.1M
EFC
Ellington Financial Inc.EFC
18.4K+9.8%
Our Bond, Inc.
 logo
Our Bond, Inc. OBAI
21.1M
MSCI logo
MSCIMSCI
410K-15.5%
Wells Fargo & Company logo
Wells Fargo & CompanyWFC
3.3B+0.9%
PNC Financial Services logo
PNC Financial ServicesPNC
$2.9B

Other financials

Income statement

See full
Revenue$311.3M+127%
Gross profit$43.5M
Operating income-$92.7M-16.9%
Net income-$94.4M-28.9%
EPS (diluted)-$3.25-24.5%

Balance sheet

See full
Cash & equivalents$232.2M+23.1%
Total debt$377.3M+187%
Total equity$543.5M-23.5%
Total assets$1.2B+23.1%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$3.8M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.66B+64.2%
Enterprise value$11.81B+67.5%
P/S10.3×-12.1×

Profitability

See full
Gross margin96.5%
Operating margin-27.7%-12.2pp
Net margin-27.3%-12.0pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-49.3%-0.8pp
Debt / equity0.7×+0.5×
Current ratio3.5×-2.4×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s common stock shares issued?
Madrigal Pharmaceuticals, Inc. (MDGL) reported common stock shares issued of 23M in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s common stock shares issued changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s common stock shares issued increased by 3.8% year-over-year, from 22.2M to 23M.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s common stock shares issued?
Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s common stock shares issued has grown at a 8.1% compound annual growth rate (CAGR), from 15.5M to 22.8M.